Liver disease may disrupt pro- and anti-haemostatic factors that involve components of primary haemostasis (platelets, fibrinogen and von Willebrand factor (VWF)), secondary haemostasis (coagulation proteins), and fibrinolysis, resulting in a state of abnormal but “re-balanced haemostasis” (Figure 1). This evidence concerns the gene VWF and liver disorder.